Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: READE SMITH who wrote (1812)	5/11/1999 6:54:00 AM
From: Tom Drolet	Read Replies (1) \| Respond to of 14101

Folks: This small bit in the Globe & Mail today, 11 May 99. Dimethaid (DMX--TSE) $4.35, up 20 cents More than 1.5 million shares of Dimethaid Research have changed hands in the past three trading sessions, and the stock price has climbed 32 per cent. Dimethaid has been touting its Pennsaid topical lotion for osteoarthritis pain relief and expects to sign a marketing deal by month's end.

To: READE SMITH who wrote (1812)	5/11/1999 7:10:00 AM
From: Jeff Chan	Respond to of 14101

Go to www.bigcharts.com... At this site you can go to the Canadian site and pull up a 10 year chart of any stock. I did this for DMX and it kind of looks like DMX's all time high is about $5.50. If there is no announcement, then it's hard to say what will happen. It's not like DMX is a huge company that everyone's following, however, with the recent volume, there's probably been increased placement into retail hands who are "buying on rumour and waiting to sell on news". Still, I would suspect it would only be a matter of days before a downturn in price if there's no announcement. Regards, Jeff